← All stocks

Damora Therapeutics, Inc.

DMRA No buying or selling
CIK 0001800315 #2097 in the set updated 17 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
$0.00
$0.00 against sales at will

By person

8 insiders · 0 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Fairmount Funds Management LLC entity
Director
2,904,000
$87.06M
Jarrett Jennifer
See Remarks
500,000
$14.99M
Hewes L. Becker
Chief Medical Officer
264,629
$7.93M
Sattarzadeh Sherwin
Chief Operating Officer
190,376
$5.71M
Bruno Julianne
Director
137,032
$4.11M
+1,606%
Schambye Hans T.
Chief Executive Officer
4,682
$140.37K
+123.2%
Winslow Garrett
General Counsel
2,289
$68.62K
+1,331%
Firmani Lori
Chief Financial Officer
931
$27.91K

No percentages here. This company's share count has moved by a factor of 46.9 over the window, from 1,316,989 to 61,735,519 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 0
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 0
History held since 4 Nov 2020